PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 23.6 EUR -6.35% Market Closed
Market Cap: 283m EUR
Have any thoughts about
PharmaSGP Holding SE?
Write Note

Balance Sheet

Balance Sheet Decomposition
PharmaSGP Holding SE

Current Assets 69.1m
Cash & Short-Term Investments 40.4m
Receivables 16m
Other Current Assets 12.7m
Non-Current Assets 65.1m
Long-Term Investments 1.8m
PP&E 1m
Intangibles 62.3m
Current Liabilities 38.6m
Accounts Payable 7.2m
Other Current Liabilities 31.5m
Non-Current Liabilities 62.9m
Long-Term Debt 61.8m
Other Non-Current Liabilities 1.1m

Balance Sheet
PharmaSGP Holding SE

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
73
77
88
8
21
33
41
Cash
73
77
88
8
21
33
41
Short-Term Investments
0
0
0
0
0
1
0
Total Receivables
7
10
11
11
7
8
9
Accounts Receivables
5
7
9
9
6
8
9
Other Receivables
2
3
2
2
1
1
0
Inventory
3
3
2
3
4
7
10
Other Current Assets
0
0
0
0
0
2
3
Total Current Assets
83
90
102
22
33
52
63
PP&E Net
0
1
0
1
1
2
1
PP&E Gross
0
1
0
1
1
2
1
Accumulated Depreciation
0
0
0
0
0
0
0
Intangible Assets
1
1
1
2
82
74
66
Long-Term Investments
0
0
0
0
0
2
1
Other Long-Term Assets
0
0
0
0
0
0
0
Total Assets
84
N/A
92
+10%
104
+13%
25
-76%
115
+362%
129
+12%
131
+2%
Liabilities
Accounts Payable
3
1
1
10
5
9
10
Short-Term Debt
1
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
85
8
8
Other Current Liabilities
7
6
7
3
3
6
7
Total Current Liabilities
10
7
8
13
93
23
25
Long-Term Debt
0
0
0
0
0
74
66
Deferred Income Tax
0
0
0
0
0
1
1
Other Liabilities
0
0
0
0
0
0
0
Total Liabilities
10
N/A
8
-26%
8
+6%
13
+65%
93
+593%
98
+5%
92
-7%
Equity
Common Stock
0
0
0
12
12
12
12
Retained Earnings
0
0
0
39
28
21
11
Additional Paid In Capital
0
0
0
38
38
38
38
Treasury Stock
0
0
0
0
0
0
0
Other Equity
74
84
96
0
0
2
1
Total Equity
74
N/A
84
+14%
96
+13%
12
-88%
22
+93%
31
+40%
40
+28%
Total Liabilities & Equity
84
N/A
92
+10%
104
+13%
25
-76%
115
+362%
129
+12%
131
+2%
Shares Outstanding
Common Shares Outstanding
12
12
12
12
12
12
12

See Also

Discover More